SCHEMBL196642

SCHEMBL196642

CN1c2ccccc2Nc2ccccc21.COS(=O)(=O)O

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
BRPF1 P55201 1/20 0.41
CHEK1 O14757 1/20 0.40
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 5/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 1/20 0.36
BRD4 O60885 1/20 0.35
RAD52 P43351 1/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
TTR P02766 1/20 0.34
CES1 P23141 1/20 0.34
MYC P01106 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30823916 1.00 GAA (0.47) GAASMN1; SMN2BRPF1CHEK1LMNA
SCHEMBL29414570 1.00 GAA (0.47) GAASMN1; SMN2BRPF1CHEK1LMNA
Sulfuric Acid SCHEMBL8008464 0.89 GAA (0.53) GAASMN1; SMN2BRPF1CHEK1KMT2A
SCHEMBL9644871 0.89 GAA (0.44) GAASMN1; SMN2BRPF1CHEK1LMNA
SCHEMBL1783719 0.87 CHEK1 (0.41) GAASMN1; SMN2BRPF1CHEK1LMNA
SCHEMBL31398538 0.85 CHEK1 (0.42) GAASMN1; SMN2BRPF1CHEK1KMT2A
SCHEMBL2490578 0.85 CHEK1 (0.42) GAASMN1; SMN2BRPF1CHEK1KMT2A
SCHEMBL4417312 0.84 SMN1; SMN2 (0.42) GAASMN1; SMN2BRPF1CHEK1KMT2A
SCHEMBL232686 0.81 GAA (0.54) GAASMN1; SMN2BRPF1CHEK1LMNA
SCHEMBL4571018 0.79 GAA (0.52) GAASMN1; SMN2BRPF1CHEK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 275 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117106806-A Preparation method of androstane-1, 4,9 (11) -triene-3, 17-diketone 湖北共同甾体药物研究院有限公司 2023-11-24 CN claimed
EP-2820145-B1 MEANS AND METHODS FOR THE DETERMINATION OF (D)-2-HYDROXYGLUTARATE (D2HG) OR (D)-2-HYDROXYADIPIC ACID DEUTSCHES KREBSFORSCH (DE) 2016-05-25 EP claimed
EP-1734362-B1 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORP (US) 2012-08-08 EP claimed
US-RE41264-E1 Biosensor with peroxidase enzyme NOVA BIOMEDICAL CORPORATION (US) 2010-04-27 US claimed
US-7648624-B2 Disposable sensor for medical use, precise, minimal blood volume needed; laminated, elongated body having a fluid sample channel connected between a fluid sample inlet on one end of the laminated body and a vent hole spaced from the inlet NOVA BIOMEDICAL CORPORATION (US) 2010-01-19 US claimed
US-7611621-B2 Such as blood glucose sensors; improving accuracy NOVA BIOMEDICAL CORPORATION (US) 2009-11-03 US claimed
US-20070023296-A1 Oxygen Sensor NOVA BIOMEDICAL CORPORATION (US) 2007-02-01 US claimed
WO-2006134518-A2 DISPOSABLE OXYGEN SENSOR AND METHOD FOR CORRECTING OXYGEN EFFECT ON OXIDASE-BASED ANALYTICAL DEVICES NOVA BIOMEDICAL CORPORATION (US) 2006-12-21 WO claimed
EP-1734362-A2 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORPORATION (US) 2006-12-20 EP claimed
US-20060278537-A1 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORPORATION (US) 2006-12-14 US claimed
US-6767441-B1 Biosensor with peroxidase enzyme NOVA BIOMEDICAL CORPORATION 2004-07-27 US claimed
US-5294540-A Quantitative assay in aqueous fluids; using tetrazolium salt, NAD+, alcohol dehydrogenase, a phenolthiazine methosulfate and poly(methyl acrylate-co-2-sulfo-1,1-dimethylethyl acrylamide-co-2-acetoacetoxyethyl methacrylate EASTMAN KODAK COMPANY (US) 1994-03-15 US claimed
EP-0239990-B1 Analytical element KONISHIROKU PHOTO IND (JP) 1993-12-15 EP claimed
WO-1993014185-A1 CONVENIENT DETERMINATION OF TRACE LEAD IN WHOLE BLOOD AND OTHER FLUIDS ANDCARE, INC. (US) 1993-07-22 WO claimed
US-5217594-A Biosensors based on isocitrate dehydrogenase enzyme ENZYME TECHNOLOGY RESEARCH GROUP, INC. (US) 1993-06-08 US claimed
EP-0464942-A1 Ethanol analytical element EASTMAN KODAK COMPANY (US) 1992-01-08 EP claimed
US-4937047-A Analytical element KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1990-06-26 US claimed
EP-0317070-A2 Digital colorimetric quantitative assay system ENZYMATICS, INC. (US) 1989-05-24 EP claimed
US-4138532-A N-methylphenazine photogalvanic cell OPTEL CORPORATION (US) 1979-02-06 US claimed
CN-119979629-A Method for preparing nitrone compounds by using non-heme bi-ferric ion type enzyme 河南师范大学 2025-05-13 CN disclosed
CN-119709673-A Alanine dehydrogenase mutant, L-alanine high-yield strain containing same and application of mutant 宁夏天新药业有限公司 2025-03-28 CN disclosed
CN-112708612-B Redox enzyme electrode for enzyme electrocatalytic reduction, preparation method thereof and enzyme electrocatalytic reactor 厦门大学 2025-02-11 CN disclosed
CN-119351485-A Preparation method of L-alanine 宁夏天新药业有限公司 2025-01-24 CN disclosed
CN-118995878-A Beta-hydroxybutyric acid detection kit and detection method thereof 苏州科铭生物技术有限公司 2024-11-22 CN disclosed
CN-114341147-B Platinum IV complex with significantly enhanced antitumor efficacy 韦埃博制药公司 2024-05-07 CN disclosed
CN-117969634-A Electrochemical detection method, device, equipment and medium for blood 三诺生物传感股份有限公司 2024-05-03 CN disclosed
CN-117947136-A Process for the preparation of estrone 湖南科益新生物医药有限公司 2024-04-30 CN disclosed
CN-117757881-A Preparation method of estradiol compound 湖南科益新生物医药有限公司 2024-03-26 CN disclosed
EP-4025581-B1 NEW PLATINUM IV COMPLEXES WITH SUBSTANTIALLY INCREASED ANTITUMOR EFFICACY VUAB PHARMA A S (CZ) 2024-02-07 EP disclosed
CN-117106806-A Preparation method of androstane-1, 4,9 (11) -triene-3, 17-diketone 湖北共同甾体药物研究院有限公司 2023-11-24 CN disclosed
EP-3461907-B1 MEASUREMENT OF GLYCOPROTEIN ARKRAY INC (JP) 2023-06-14 EP disclosed
EP-4025581-A1 NEW PLATINUM IV COMPLEXES WITH SUBSTANTIALLY INCREASED ANTITUMOR EFFICACY VUAB Pharma a.s. (CZ) 2022-07-13 EP disclosed
WO-2021043402-A1 NEW PLATINUM IV COMPLEXES WITH SUBSTANTIALLY INCREASED ANTITUMOR EFFICACY VUAB PHARMA A.S. (CZ) 2021-03-11 WO disclosed
CN-111315894-A Detection of creatine levels with enzyme compositions IP2IPO 创新公司 2020-06-19 CN disclosed
US-10571425-B2 Disposable test sensor with improved sampling entrance CHANGSHA SINOCARE INC. (CN) 2020-02-25 US disclosed
US-10422791-B2 Haptens and conjugates derived from pyocyanin, antibodies thereof, and immunochemical method for detecting infections caused by Pseudomonas aeruginosa CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIS) (ES) 2019-09-24 US disclosed
US-10386323-B2 Test sensor with multiple sampling routes SINOCARE INC. (CN) 2019-08-20 US disclosed
US-20190170678-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2019-06-06 US disclosed
EP-3461907-A1 MEASUREMENT OF GLYCOPROTEIN ARKRAY, Inc. (JP) 2019-04-03 EP disclosed
US-10247693-B2 Disposable test sensor with improved sampling entrance CHANGSHA SINOCARE INC. (CN) 2019-04-02 US disclosed
US-20190017956-A1 DISPOSABLE TEST SENSOR CHANGSHA SINOCARE INC. (CN) 2019-01-17 US disclosed
US-20180364191-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2018-12-20 US disclosed
US-10088444-B2 Disposable test sensor with improved sampling entrance CHANGSHA SINOCARE INC. (CN) 2018-10-02 US disclosed
EP-3189064-B1 PLATINUM (IV) COMPLEX WITH INCREASED ANTITUMOR EFFICACY VUAB PHARMA A S (CZ) 2018-08-08 EP disclosed
US-20180188198-A1 TEST SENSOR WITH MULTIPLE SAMPLING ROUTES CHANGSHA SINOCARE INC. (CN) 2018-07-05 US disclosed
US-20180128767-A1 Small Volume In Vitro Analyte Sensor ABBOTT DIABETES CARE INC. (US) 2018-05-10 US disclosed
US-9939401-B2 Test sensor with multiple sampling routes CHANGSHA SINOCARE INC. (CN) 2018-04-10 US disclosed
US-9897566-B2 Disposable test sensor CHANGSHA SINOCARE INC. (CN) 2018-02-20 US disclosed
EP-2966066-B1 HAPTENES AND CONJUGATES DERIVED FROM PYOCYANIN, ANTIBODIES THEREOF, AND IMMUNOCHEMICAL METHOD FOR DETECTING INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS (CSIC) (ES) 2018-02-14 EP disclosed
US-9891185-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2018-02-13 US disclosed
EP-3189064-A1 PLATINUM (IV) COMPLEX WITH INCREASED ANTITUMOR EFFICACY Vuab Pharma A. S. (CZ) 2017-07-12 EP disclosed
US-9662057-B2 Integrated sample acquisition and analyte measurement method ABBOTT DIABETES CARE INC. (US) 2017-05-30 US disclosed
US-20170052139-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2017-02-23 US disclosed
US-20170052138-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2017-02-23 US disclosed
US-9523653-B2 Disposable test sensor with improved sampling entrance CHANGSHA SINOCARE INC. (CN) 2016-12-20 US disclosed
US-9518951-B2 Disposable test sensor with improved sampling entrance CHANGSHA SINOCARE INC. (CN) 2016-12-13 US disclosed
US-20160334356-A1 Small Volume In Vitro Analyte Sensor THERASENSE, INC. 2016-11-17 US disclosed
US-20160235350-A1 Integrated Sample Acquisition and Analyte Measurement Device THERASENSE, INC. 2016-08-18 US disclosed
US-9341591-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2016-05-17 US disclosed
US-9316609-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2016-04-19 US disclosed
US-9291592-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2016-03-22 US disclosed
WO-2016034214-A1 PLATINUM (IV) COMPLEX WITH INCREASED ANTITUMOR EFFICACY VUAB PHARMA A.S. (CZ) 2016-03-10 WO disclosed
EP-2066679-B1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF ÆTERNA ZENTARIS GMBH (DE) 2016-03-09 EP disclosed
US-9271669-B2 Method for integrated sample acquisition and analyte measurement device ABBOTT DIABETES CARE INC. (US) 2016-03-01 US disclosed
US-20160033489-A1 Haptenes and Conjugates Derived from Pyocyanin, Antibodies Thereof, and Immunichemical Method for Detecting Infections Caused by Pseudomonas Aeruginosa UNIVERSIDAD AUTONOMA DE BARCELONA (ES) 2016-02-04 US disclosed
EP-2966066-A1 HAPTENES AND CONJUGATES DERIVED FROM PYOCYANIN, ANTIBODIES THEREOF, AND IMMUNOCHEMICAL METHOD FOR DETECTING INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA Consejo Superior De Investigaciones Científicas (CSIC) (ES) 2016-01-13 EP disclosed
US-9234863-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2016-01-12 US disclosed
US-20150245791-A1 Integrated Sample Acquisition and Analyte Measurement Device THERASENSE, INC. 2015-09-03 US disclosed
WO-2015126456-A1 TEST SENSOR WITH MULTIPLE SAMPLING ROUTES CAI XIAOHUA (US) 2015-08-27 WO disclosed
US-20150233861-A1 TEST SENSOR WITH MULTIPLE SAMPLING ROUTES CHANGSHA SINOCARE INC. (CN) 2015-08-20 US disclosed
US-20150198554-A1 DISPOSABLE TEST SENSOR CHANGSHA SINOCARE INC. (CN) 2015-07-16 US disclosed
WO-2015105536-A1 DISPOSABLE TEST SENSOR CAI XIAOHUA (US) 2015-07-16 WO disclosed
WO-2015084448-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CAI XIAOHUA (US) 2015-06-11 WO disclosed
US-20150160150-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2015-06-11 US disclosed
US-9017259-B2 Integrated sample acquisition and analyte measurement device ABBOTT DIABETES CARE INC. (US) 2015-04-28 US disclosed
US-20140332414-A1 DISPOSABLE TEST SENSOR WITH IMPROVED SAMPLING ENTRANCE CHANGSHA SINOCARE INC. (CN) 2014-11-13 US disclosed
US-20140251828-A1 Small Volume In Vitro Analyte Sensor ABBOTT DIABETES CARE INC. (US) 2014-09-11 US disclosed
US-20140251827-A1 Small Volume In Vitro Analyte Sensor ABBOTT DIABETES CARE INC. (US) 2014-09-11 US disclosed
US-20140251830-A1 Small Volume In Vitro Analyte Sensor ABBOTT DIABETES CARE, INC. (US) 2014-09-11 US disclosed
US-20140251829-A1 Small Volume In Vitro Analyte Sensor ABBOTT DIABETES CARE INC. (US) 2014-09-11 US disclosed
US-8795176-B2 Integrated sample acquisition and analyte measurement device ABBOTT DIABETES CARE INC. (US) 2014-08-05 US disclosed
US-8728297-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2014-05-20 US disclosed
US-8701282-B2 Method for manufacturing a biosensor ABBOTT DIABETES CARE INC. (US) 2014-04-22 US disclosed
US-8650751-B2 Methods of making small volume in vitro analyte sensors ABBOTT DIABETES CARE INC. (US) 2014-02-18 US disclosed
US-8604196-B2 Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea AETERNA ZENTARIS GMBH (DE) 2013-12-10 US disclosed
US-20130296346-A1 DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FAES FARMA, S.A. (ES) 2013-11-07 US disclosed
EP-2642987-A1 DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS Faes Farma, S.A. (ES) 2013-10-02 EP disclosed
US-8536332-B2 Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines AETERNA ZENTARIS GMBH (DE) 2013-09-17 US disclosed
US-8532731-B2 Methods of determining analyte concentration ABBOTT DIABETES CARE INC. (US) 2013-09-10 US disclosed
US-8507486-B2 Pyridopyrazine derivatives, process of manufacturing and uses thereof AETERNA ZENTARIS GMBH (DE) 2013-08-13 US disclosed
US-8470776-B2 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof AETERNA ZENTARIS GMBH (DE) 2013-06-25 US disclosed
US-20130157976-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES CLAUS ECKHARD (DE) 2013-06-20 US disclosed
US-8449758-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2013-05-28 US disclosed
US-8425758-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2013-04-23 US disclosed
US-8425743-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2013-04-23 US disclosed
US-8377378-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2013-02-19 US disclosed
US-8372261-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2013-02-12 US disclosed
US-8338153-B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme DUPONT NUTRITION BIOSCIENCES APS (DK) 2012-12-25 US disclosed
US-20120277219-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2012-11-01 US disclosed
US-20120252760-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES ZENTARIS GMBH (DE) 2012-10-04 US disclosed
US-8273241-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-09-25 US disclosed
US-8268144-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-09-18 US disclosed
US-20120214768-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2012-08-23 US disclosed
US-20120209050-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2012-08-16 US disclosed
EP-1734362-B1 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORP (US) 2012-08-08 EP disclosed
US-8226815-B2 Small volume in vitro sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-07-24 US disclosed
US-8221685-B2 Small volume in vitro sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-07-17 US disclosed
US-8217042-B2 Pyridopyrazines and their use as modulators of kinases ZENTARIS GMBH (DE) 2012-07-10 US disclosed
US-8211363-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-07-03 US disclosed
EP-2465498-A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions FAES FARMA, S.A. (ES) 2012-06-20 EP disclosed
US-8202883-B2 Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases AETERNA ZENTARIS GMBH (DE) 2012-06-19 US disclosed
US-8192611-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-06-05 US disclosed
WO-2012069442-A1 DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FAES FARMA, S.A. (ES) 2012-05-31 WO disclosed
US-8186044-B2 Method of manufacturing small volume in vitro analyte sensors ABBOTT DIABETES CARE INC. (US) 2012-05-29 US disclosed
US-8187895-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-05-29 US disclosed
US-8182670-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-05-22 US disclosed
US-8182671-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-05-22 US disclosed
US-8178090-B2 Recombinant hexose oxidase DANISCO A/S (DK) 2012-05-15 US disclosed
US-8163164-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-04-24 US disclosed
US-8153063-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-04-10 US disclosed
US-8118993-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2012-02-21 US disclosed
US-8091220-B2 Methods of making small volume in vitro analyte sensors ABBOTT DIABETES CARE INC. (US) 2012-01-10 US disclosed
US-8087162-B2 Methods of making small volume in vitro analyte sensors ABBOTT DIABETES CARE INC. (US) 2012-01-03 US disclosed
US-8083928-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2011-12-27 US disclosed
US-8083929-B2 Small volume in vitro sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2011-12-27 US disclosed
US-8083924-B2 Small volume in vitro analyte sensor and methods of making ABBOTT DIABETES CARE INC. (US) 2011-12-27 US disclosed
EP-1119637-B2 SMALL VOLUME IN VITRO ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR ABBOTT DIABETES CARE INC (US) 2011-11-02 EP disclosed
EP-1756112-B1 PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS BOEHRINGER INGELHEIM INT (DE) 2011-10-26 EP disclosed
US-8008324-B2 Antitumor agents; N-propargyl-N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indol-3-yl]glyoxylamide AETERNA ZENTARIS GMBH (DE) 2011-08-30 US disclosed
US-7989453-B2 Antitumor agents; for example, N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indole-3-yl]glyoxylamide AETERNA ZENTARIS GMBH (DE) 2011-08-02 US disclosed
US-20110183037-A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme DANISCO A/S (DK) 2011-07-28 US disclosed
US-20100323963-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2010-12-23 US disclosed
US-20100317580-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2010-12-16 US disclosed
US-20100243478-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-09-30 US disclosed
US-20100170793-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-07-08 US disclosed
US-20100167311-A1 Oxidoreductases and Processes Utilising Such Enzymes THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2010-07-01 US disclosed
US-7745599-B1 Hexose oxidase-encoding DNAs and methods of use thereof DANISCO A/S (DK) 2010-06-29 US disclosed
US-7740581-B2 Methods of determining concentration of glucose ABBOTT DIABETES CARE INC. (US) 2010-06-22 US disclosed
US-7741277-B2 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof AETERNA ZENTARIS GMBH (DE) 2010-06-22 US disclosed
US-7727572-B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme DANISCO A/S (DK) 2010-06-01 US disclosed
US-RE41264-E1 Biosensor with peroxidase enzyme NOVA BIOMEDICAL CORPORATION (US) 2010-04-27 US disclosed
US-20100087722-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-04-08 US disclosed
US-20100086954-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-04-08 US disclosed
US-20100086961-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-04-08 US disclosed
US-20100081907-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-04-01 US disclosed
US-20100081152-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-04-01 US disclosed
US-20100076287-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-03-25 US disclosed
US-20100076286-A1 Small Volume In Vitro Analyte Sensor and Methods of Making THERASENSE, INC. 2010-03-25 US disclosed
US-20100076285-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-03-25 US disclosed
EP-2164849-A2 PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF AEterna Zentaris GmbH (DE) 2010-03-24 EP disclosed
US-20100047841-A1 SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2010-02-25 US disclosed
US-20100036220-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-02-11 US disclosed
US-20100032317-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-02-11 US disclosed
US-20100018877-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018050-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100019407-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018873-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018870-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018051-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018872-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018869-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018874-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100021659-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018875-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100018871-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-28 US disclosed
US-20100012522-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012524-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012520-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012521-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012523-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012525-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012519-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012517-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100015692-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012492-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012518-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100015326-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012516-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-20100012526-A1 Small Volume In Vitro Sensor and Methods of Making THERASENSE, INC. 2010-01-21 US disclosed
US-7648624-B2 Disposable sensor for medical use, precise, minimal blood volume needed; laminated, elongated body having a fluid sample channel connected between a fluid sample inlet on one end of the laminated body and a vent hole spaced from the inlet NOVA BIOMEDICAL CORPORATION (US) 2010-01-19 US disclosed
US-20090275103-A1 Recombinant hexose oxidase DANISCO A/S (DK) 2009-11-05 US disclosed
WO-2008106080-A9 SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 WO disclosed
US-20090275534-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF ZENTARIS GMBH (DE) 2009-11-05 US disclosed
US-7611621-B2 Such as blood glucose sensors; improving accuracy NOVA BIOMEDICAL CORPORATION (US) 2009-11-03 US disclosed
US-20090270764-A1 METHODS OF DETERMINING CONCENTRATION OF KETONE BODIES ABBOTT DIABETES CARE INC. 2009-10-29 US disclosed
US-20090223834-A1 Biosensor and method NOVA BIOMEDICAL CORPORATION (US) 2009-09-10 US disclosed
US-7563350-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2009-07-21 US disclosed
US-7550069-B2 Small volume in vitro analyte sensor ABBOTT DIABETES CARE INC. (US) 2009-06-23 US disclosed
US-7547383-B2 Biosensor and method NOVA BIOMEDICAL CORPORATION (US) 2009-06-16 US disclosed
EP-2066679-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF AEterna Zentaris GmbH (DE) 2009-06-10 EP disclosed
US-7544795-B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme DANISCO A/S (DK) 2009-06-09 US disclosed
US-20090041899-A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme DANISCO A/S (DK) 2009-02-12 US disclosed
US-20090014328-A1 Small Volume in vitro Analyte Sensor and Methods of Making ABBOTT DIABETES CARE INC. (US) 2009-01-15 US disclosed
WO-2008138878-A2 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF ÆTERNA ZENTARIS GMBH (DE) 2008-11-20 WO disclosed
EP-1990342-A1 Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof AEterna Zentaris GmbH (DE) 2008-11-12 EP disclosed
EP-1987154-A2 OXIDOREDUCTASES AND PROCESSES UTILISING SUCH ENZYMES LEIDEN UNIVERSITY (NL) 2008-11-05 EP disclosed
EP-0832245-B2 RECOMBINANT HEXOSE OXIDASE, A METHOD OF PRODUCING SAME AND USE OF SUCH ENZYME DANISCO (DK) 2008-09-10 EP disclosed
WO-2008106080-A2 SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-09-04 WO disclosed
US-20080153875-A1 Novel indole derivatives and their use as medicament AETERNA ZENTARIS GMBH (DE) 2008-06-26 US disclosed
US-20080108819-A1 Novel indole derivatives and their use as medicament AETERNA ZENTARIS GMBH (DE) 2008-05-08 US disclosed
US-7365081-B2 Indole derivatives and their use as medicaments AETERNA ZENTARIS GMBH (DE) 2008-04-29 US disclosed
US-20080090758-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2008-04-17 US disclosed
EP-1900742-A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof AEterna Zentaris GmbH (DE) 2008-03-19 EP disclosed
WO-2008028934-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF AETERNA ZENTARIS GMBH (DE) 2008-03-13 WO disclosed
US-20080027302-A1 Integrated Sample Acquisition and Analyte Measurement Device THERASENSE, INC. (US) 2008-01-31 US disclosed
US-20070193019-A1 SMALL VOLUME IN VITRO SENSOR AND METHODS OF MAKING ABBOTT DIABETES CARE, INC. (US) 2007-08-23 US disclosed
WO-2007090873-A2 OXIDOREDUCTASES AND PROCESSES UTILISING SUCH ENZYMES LEIDEN UNIVERSITY (NL) 2007-08-16 WO disclosed
US-20070149484-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES ZENTARIS GMBH (DE) 2007-06-28 US disclosed
US-7225535-B2 Method of manufacturing electrochemical sensors ABBOTT DIABETES CARE, INC. (US) 2007-06-05 US disclosed
EP-1756112-A1 PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS Boehringer Ingelheim International GmbH (DE) 2007-02-28 EP disclosed
US-20070023296-A1 Oxygen Sensor NOVA BIOMEDICAL CORPORATION (US) 2007-02-01 US disclosed
WO-2006134518-A2 DISPOSABLE OXYGEN SENSOR AND METHOD FOR CORRECTING OXYGEN EFFECT ON OXIDASE-BASED ANALYTICAL DEVICES NOVA BIOMEDICAL CORPORATION (US) 2006-12-21 WO disclosed
EP-1734362-A2 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORPORATION (US) 2006-12-20 EP disclosed
US-20060278537-A1 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices NOVA BIOMEDICAL CORPORATION (US) 2006-12-14 US disclosed
US-20060169599-A1 Non-leachable or diffusible redox mediator; for glucose or lactate concentrations THERASENSE, INC. (US) 2006-08-03 US disclosed
US-7058437-B2 Methods of determining concentration of glucose THERASENSE, INC. (US) 2006-06-06 US disclosed
EP-1645556-A1 Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents Boehringer Ingelheim International GmbH (DE) 2006-04-12 EP disclosed
US-20060025662-A1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator THERASENSE, INC. (US) 2006-02-02 US disclosed
US-20050278945-A1 Small volume in vitro analyte sensor THERASENSE, INC. (US) 2005-12-22 US disclosed
US-20050282249-A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme DUPONT NUTRITION BIOSCIENCES APS (DK) 2005-12-22 US disclosed
WO-2005111040-A1 PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed
EP-1598353-A1 Pyrrolobenzimidazolones and their use as antiproliferative agents Boehringer Ingelheim International GmbH (DE) 2005-11-23 EP disclosed
US-6936615-B2 Heteroaryl derivatives and their use as medicaments ZENTARIS GMBH (DE) 2005-08-30 US disclosed
US-6924366-B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme BIOTEKNOLOGISK INSTITUT (DK) 2005-08-02 US disclosed
US-20050009809-A1 Aryl- and heteroaryl-substituted piperazinylcarbonyl acridines and their homologs, e.g., (1,3-dihydroxyacridin-9-yl)-[4-(6-methyl pyridin-2-yl )piperazin-1-yl]methanone,are suitable for treating benign and malignant tumors ZENTARIS GMBH (DE) 2005-01-13 US disclosed
US-20040217019-A1 Biosensor and method CAI XIAOHUA (US) 2004-11-04 US disclosed
US-6790612-B2 EXPRESSION VECTORS WHICH EVALUATES SENSITIVITY OF HEPATITIS VIRUS TO VIRICIDES/ENZYME INHIBITORS VIA MONITORING DECREASE OR INCREASE IN SECRETION OF ALKALINE PHOSPHATASE (SEAP) AGOURON PHARMACEUTICALS, INC. 2004-09-14 US disclosed
US-6767441-B1 Biosensor with peroxidase enzyme NOVA BIOMEDICAL CORPORATION 2004-07-27 US disclosed
US-20040132747-A1 Novel heteroaryl derivatives and their use as medicaments ZENTARIS AG (DE) 2004-07-08 US disclosed
US-20040097734-A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses ZENTARIS GMBH (DE) 2004-05-20 US disclosed
US-20040060818-A1 Small volume in vitro analyte sensor and methods of making THERASENSE, INC. (US) 2004-04-01 US disclosed
EP-1119637-B1 SMALL VOLUME IN VITRO ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR THERASENSE INC (US) 2004-03-24 EP disclosed
US-20040054267-A1 Small volume in vitro analyte sensor THERASENSE, INC. 2004-03-18 US disclosed
US-6706722-B2 IN PARTICULAR FOR TREATING TUMORS. ZENTARIS AG (DE) 2004-03-16 US disclosed
EP-1379666-A2 RECOMBINANT DIMORPHIC FUNGAL CELL Arnau, José (DK) 2004-01-14 EP disclosed
US-20030199744-A1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator THERASENSE, INC. (US) 2003-10-23 US disclosed
US-20030175692-A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease AGOURON PHARMACEUTICALS, INC. 2003-09-18 US disclosed
US-6618934-B1 Method of manufacturing small volume in vitro analyte sensor THERASENSE, INC. 2003-09-16 US disclosed
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents BAXTER ONCOLOGY GMBH 2003-08-21 US disclosed
EP-1102992-A4 REPORTER GENE SYSTEM FOR USE IN CELL-BASED ASSESSMENT OF INHIBITORS OF THE HEPATITIS C VIRUS PROTEASE AGOURON PHARMA (US) 2003-07-30 EP disclosed
US-6599738-B2 Recombinant plasmid which comprises a Hepatitis C virus/secreted alkaline phosphatase (SEAP) gene construct operably linked to a promoter compatible with an RNA polymerase AGOURON PHARMACEUTICALS, INC. 2003-07-29 US disclosed
US-20030134353-A1 Recombinant dimorphic fungal cell BIOTEKNOLOGISK INSTITUT (DK) 2003-07-17 US disclosed
US-6592745-B1 Analytical sensors for the detection of bioanalytes in a small volume sample; to monitor glucose in diabetic patients and lactate during critical care THERASENSE, INC. 2003-07-15 US disclosed
US-6591125-B1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator THERASENSE, INC. 2003-07-08 US disclosed
US-20030100597-A1 Novel indole derivatives and their use as medicaments AETERNA ZENTARIS GMBH (DE) 2003-05-29 US disclosed
US-20030082518-A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease AGOURON PHARMACEUTICALS, INC. 2003-05-01 US disclosed
WO-2003012422-A1 IMPROVED BIOSENSOR AND METHOD NOVA BIOMEDICAL CORPORATION (US) 2003-02-13 WO disclosed
US-6461496-B1 BLOOD GLUCOSE THERASENSE, INC. 2002-10-08 US disclosed
US-20020132821-A1 Novel heteroaryl derivatives and their use as medicaments ZENTARIS GMBH (DE) 2002-09-19 US disclosed
WO-2002070721-A2 RECOMBINANT DIMORPHIC FUNGAL CELL BIOTEKNOLOGISK INSTITUT (DK) 2002-09-12 WO disclosed
EP-0832245-B1 RECOMBINANT HEXOSE OXIDASE, A METHOD OF PRODUCING SAME AND USE OF SUCH ENZYME DANISCO (DK) 2002-09-04 EP disclosed
US-20020106725-A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme BIOTEKNOLOGISK INSTITUT 2002-08-08 US disclosed
US-6338790-B1 DETECTION OF BIOANALYTES IN A SMALL VOLUME SAMPLE; CONCENTRATION OF A BIOMOLECULE, SUCH AS GLUCOSE OR LACTATE, USING TECHNIQUES SUCH AS COULOMETRY, AMPEROMETRY, AND POTENTIOMETRY. AN ENZYME CAPABLE OF CATALYZING THE THERASENSE, INC. 2002-01-15 US disclosed
US-6299757-B1 ANALYTICAL SENSORS FOR THE DETECTION OF BIOANALYTES; ESPECIALLY MONITORING GLUCOSE LEVELS IN DIABETIC PATIENTS THERASENSE, INC. 2001-10-09 US disclosed
US-6280940-B1 Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease AGOURON PHARMACEUTICALS, INC. 2001-08-28 US disclosed
US-6251626-B1 GENERATING ENZYMATIC POLYPEPTIDE; INSERT EXPRESSION VECTOR INTO CELL, CULTURE CELLS, RECOVER ENZYMATIC POLYPEPTIDE BIOTEKNOLOGISK INSTITUT (DK) 2001-06-26 US disclosed
EP-1102992-A1 REPORTER GENE SYSTEM FOR USE IN CELL-BASED ASSESSMENT OF INHIBITORS OF THE HEPATITIS C VIRUS PROTEASE AGOURON PHARMACEUTICALS, INC. (US) 2001-05-30 EP disclosed
EP-1020523-A2 Recombinant hexose oxidase, a method of producing same and use of such enzyme Bioteknologisk Institut (DK) 2000-07-19 EP disclosed
WO-2000008469-A1 REPORTER GENE SYSTEM FOR USE IN CELL-BASED ASSESSMENT OF INHIBITORS OF THE HEPATITIS C VIRUS PROTEASE AGOURON PHARMACEUTICALS, INC. (US) 2000-02-17 WO disclosed
EP-0695746-A2 Antiviral compounds and pharmaceutical compositions PHARMA MAR, S.A. (ES) 1996-02-07 EP disclosed
US-5368707-A Electrochemistry, bioelectrode of immobilized enzyme ANDCARE, INC. (US) 1994-11-29 US disclosed
EP-0239990-B1 Analytical element KONISHIROKU PHOTO IND (JP) 1993-12-15 EP disclosed
WO-1993014185-A1 CONVENIENT DETERMINATION OF TRACE LEAD IN WHOLE BLOOD AND OTHER FLUIDS ANDCARE, INC. (US) 1993-07-22 WO disclosed
US-5217594-A Biosensors based on isocitrate dehydrogenase enzyme ENZYME TECHNOLOGY RESEARCH GROUP, INC. (US) 1993-06-08 US disclosed
EP-0244825-B1 DRY-TYPE ANALYTICAL ELEMENT FOR CHOLESTEROL FUJI PHOTO FILM CO., LTD. (JP) 1992-10-07 EP disclosed
US-5124141-A METHOD FOR DIAGNOSING MALARIA FLOW INCORPORATED (US) 1992-06-23 US disclosed
US-5059526-A Storage stability, accuracy KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1991-10-22 US disclosed
US-4937047-A Analytical element KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1990-06-26 US disclosed
EP-0317070-A2 Digital colorimetric quantitative assay system ENZYMATICS, INC. (US) 1989-05-24 EP disclosed
EP-0244825-A1 Dry-type analytical element for cholesterol FUJI PHOTO FILM CO., LTD. (JP) 1987-11-11 EP disclosed
EP-0239990-A2 Analytical element KONICA CORPORATION (JP) 1987-10-07 EP disclosed
US-4138532-A N-methylphenazine photogalvanic cell OPTEL CORPORATION (US) 1979-02-06 US disclosed
US-4118546-A Triple electrode photogalvanic cell with energy storage capability OPTEL CORPORATION (US) 1978-10-03 US disclosed
US-4080488-A Dye-titanium dioxide photogalvanic cell OPTEL CORPORATION (US) 1978-03-21 US disclosed
US-4080488-A Dye-titanium dioxide photogalvanic cell OPTEL CORPORATION (US) 1978-03-21 US disclosed
US-4080488-A Dye-titanium dioxide photogalvanic cell OPTEL CORPORATION (US) 1978-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (22 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296346-A1 DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CYP2D6, DDC, PAH GAA 1191/4885SMN1; SMN2 3358/4885BRPF1 2666/4885
US-20120214768-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF PNPO, PDXK, MKI67 GAA 3256/4885SMN1; SMN2 742/4885BRPF1 265/4885
US-20050009809-A1 Aryl- and heteroaryl-substituted piperazinylcarbonyl acridines and their homologs, e.g., (1,3-dihydroxyacridin-9-yl)-[4-(6-methyl pyridin-2-yl )piperazin-1-yl]methanone,are suitable for treating benign and malignant tumors PKD1, MDH2, MSH2 GAA 3585/4885SMN1; SMN2 4451/4885BRPF1 3172/4885
US-20040132747-A1 Novel heteroaryl derivatives and their use as medicaments CYP11B2, GLS2, ABCB1 GAA 605/4885SMN1; SMN2 4547/4885BRPF1 3441/4885
US-10422791-B2 Haptens and conjugates derived from pyocyanin, antibodies thereof, and immunochemical method for detecting infections caused by Pseudomonas aeruginosa PAH, HRH1, P4HA1 GAA 1977/4885SMN1; SMN2 4514/4885BRPF1 1871/4885
US-20070149484-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES MAP4K2, MAP3K15, MAP3K5 GAA 3721/4885SMN1; SMN2 2430/4885BRPF1 772/4885
US-20080153875-A1 Novel indole derivatives and their use as medicament IDO1, TPH1, IDO2 GAA 3216/4885SMN1; SMN2 4164/4885BRPF1 4148/4885
US-20120252760-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES MAP4K2, MAP3K15, MAP3K5 GAA 3721/4885SMN1; SMN2 2430/4885BRPF1 772/4885
US-20090275534-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF PNPO, PDXK, MKI67 GAA 3256/4885SMN1; SMN2 742/4885BRPF1 265/4885
US-20030100597-A1 Novel indole derivatives and their use as medicaments IDO1, TPH1, IDO2 GAA 3276/4885SMN1; SMN2 4400/4885BRPF1 3941/4885
US-20020132821-A1 Novel heteroaryl derivatives and their use as medicaments ABCB1, ABCB11, FANCD2 GAA 483/4885SMN1; SMN2 4629/4885BRPF1 3316/4885
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT GAA 4099/4885SMN1; SMN2 4036/4885BRPF1 4047/4885
US-20120277219-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF PNPO, PDXK, MKI67 GAA 3256/4885SMN1; SMN2 742/4885BRPF1 265/4885
US-20160033489-A1 Haptenes and Conjugates Derived from Pyocyanin, Antibodies Thereof, and Immunichemical Method for Detecting Infections Caused by Pseudomonas Aeruginosa HPD, HRH1, TLR5 GAA 1929/4885SMN1; SMN2 4561/4885BRPF1 2828/4885
US-20100323963-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF EPCAM, CD99, PTMS GAA 1185/4885SMN1; SMN2 4841/4885BRPF1 1986/4885
US-20100317580-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF EPCAM, CD99, PTMS GAA 1185/4885SMN1; SMN2 4841/4885BRPF1 1986/4885
US-20080108819-A1 Novel indole derivatives and their use as medicament IDO1, TPH1, IDO2 GAA 3216/4885SMN1; SMN2 4164/4885BRPF1 4148/4885
US-20040097734-A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses VHL, MYC, HCCS GAA 1129/4885SMN1; SMN2 4262/4885BRPF1 2364/4885
US-20080090758-A1 CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF EPCAM, CD99, PTMS GAA 1185/4885SMN1; SMN2 4841/4885BRPF1 1986/4885
US-20130157976-A1 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES MAP4K2, MAP3K15, MAP3K5 GAA 3721/4885SMN1; SMN2 2430/4885BRPF1 772/4885
US-20120209050-A1 NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF PNPO, PDXK, MKI67 GAA 3256/4885SMN1; SMN2 742/4885BRPF1 265/4885
US-20100047841-A1 SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF XDH, XPA, TPX2 GAA 405/4885SMN1; SMN2 3326/4885BRPF1 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.